And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…

This is the online version of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. Maybe I don’t say this enough: Thank…

Europe’s comparatively cautious approach to food additives is the envy of health secretary Robert F. Kennedy Jr. and the Make America Healthy Again movement. A Texas bill now before Gov.…

We recently went viral. Well, not exactly us — but people like us. We are participants in the Yale LISTEN Study, a patient-centered study to better understand long Covid and…

Metsera’s obesity drug candidate targeting the amylin hormone showed marked efficacy in an early trial and the potential to have longer-lasting effects than current weight loss treatments on the market…

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions.Budget documents released by the Trump administration Friday provide the first clear indication of the priorities…

WASHINGTON — President Trump’s 2026 budget proposes slashing the National Institutes of Health’s central function, supporting research by awarding grants to universities, academic medical centers, and other institutions, by 43%…

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech…

This is the online version of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. I’m back! Sorry for the unannounced break…

When the Trump administration put a pause on student visa interviews recently, it hit a perhaps surprising group: thousands of J-1 physician visa holders who are supposed to start residency…